Skip to main content

Analysis of trefoil factor family protein 1 (TFF1, pS2) expression in chronic cholecystitis and gallbladder carcinoma

Virchows Archiv volume 446, pages 505–510 (2005)Cite this article

Abstract

Trefoil factor family protein 1 (TFF1, pS2) interacts with mucins to protect gastrointestinal epithelium against injury and contributes to mucosal repair by promoting epithelial cell migration and restitution. Moreover, TFF1 has antiproliferative and anti-apoptotic effects and promotes cell scattering and invasion. We investigated TFF1 expression in healthy and inflamed non-neoplastic gallbladder mucosa as well as in gallbladder carcinomas (n=57) and corresponding metastases (n=18), using a tissue microarray technique. TFF1 immunoreactivity was absent in healthy mucosa, focally observed in epithelium with inflammatory changes and present in 35% of primary and 24% of metastatic cancer tissues. Immunoreactivity significantly decreased with increasing tumour stage (P=0.009) and increasing tumour grade (P=0.001). Patients with TFF1 positive tumours showed a more favourable outcome compared to patients with TFF1 negative tumours in univariate analysis (P=0.006). However, multivariate analysis proved resection status and tumour grade as the only independent prognostic factors. In conclusion, TFF1 is expressed in inflamed non-neoplastic gallbladder epithelium and in low stage and low grade gallbladder carcinomas. Thus, TFF1 may be the missing link between gallstones, chronic cholecystitis and gallbladder cancer. Further studies are needed to evaluate whether TFF1 immunostaining can be used as a diagnostic tool to identify patients with a more favourable outcome.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Albores-Saavedra J, Scoazec JC, Wittekind C, Sripa B, Menck HR, Soehendra N, Sriram PVJ (2000) Tumours of the gallbladder and extrahepatic bile ducts. In: Hamilton SR, Aaltonen LA (eds) WHO classification of tumours. Pathology and genetics. Tumours of the digestive system. IARC Press, Lyon, pp 203–218

    Google Scholar 

  2. Balleine RL, Clarke CL (1999) Expression of the oestrogen responsive protein pS2 in human breast cancer. Histol Histopathol 14:571–578

    Google Scholar 

  3. Bossenmeyer-Pourié C, Kannan R, Ribieras S, Wendling C, Stoll I, Thim L, Tomasetto C, Rio MC (2002) The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis. J Cell Biol 157:761–770

    Google Scholar 

  4. Donohue JH, Stewart AK, Menck HR (1998) The national cancer data base report on carcinoma of the gallbladder, 1989–1995. Cancer 83:2618–2628

    Google Scholar 

  5. Emami S, Le Floch N, Bruyneel E, Thim L, May F, Westley B, Rio MC, Mareel M, Gespach C (2001) Induction of scattering and cellular invasion by trefoil peptides in src- and RhoA-transformed kidney and colonic epithelial cells. FASEB J 15:351–361

    Google Scholar 

  6. Hackel C, Falkenberg B, Gunther T, Lippert H, Roessner A (1998) The pS2 protein in colorectal carcinomas and metastases. Pathol Res Pract 94:171–176

    Google Scholar 

  7. Higashiyama M, Doi O, Kodama K, Yokouchi H, Inaji H, Nakamori S, Tateishi R (1994) Prognostic significance of pS2 protein expression in pulmonary adenocarcinoma. Eur J Cancer 30A:792–797

    Google Scholar 

  8. Ito H, Matros E, Brooks DC, Osteen RT, Zinner MJ, Swanson RS, Ashley SW, Whang EE (2004) Treatment outcomes associated with surgery for gallbladder cancer: a 20-year experience. J Gastrointest Surg 8:183–190

    Google Scholar 

  9. Katoh M (2003) Trefoil factors and human gastric cancer. Int J Mol Med 12:3–9

    Google Scholar 

  10. Kirikoshi H, Katoh M (2002) Expression of TFF1, TFF2 and TFF3 in gastric cancer. Int J Oncol 21:655–659

    Google Scholar 

  11. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844–847

    CAS  PubMed  Google Scholar 

  12. Koshiyama M, Yoshida M, Konishi M, Takemura M, Yura Y, Matsushita K, Hayashi M, Tauchi K (1997) Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status. Int J Cancer 74:237–244

    Google Scholar 

  13. Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II, Alonso de Ruiz P, Aristi Urista G, Nervi F (2001) Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 51:349–364

    Google Scholar 

  14. Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M, Wendling C, Tomasetto P, Chambon P, Rio MC (1996) Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274:259–262

    Google Scholar 

  15. Leung WK, Yu J, Chan FK, To KF, Chan MW, Ebert MP, Ng EK, Chung SC, Malfertheiner P, Sung JJ (2002) Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J Pathol 197:582–588

    Google Scholar 

  16. Li X, Hui AM, Shi YZ, Takayama T, Makuuchi M (2001) Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder. Hum Pathol 32:771–777

    Google Scholar 

  17. Lipponen PK, Eskelinen MJ (1994) Expression of pS2 protein transitional cell bladder tumours. J Pathol 173:327–332

    Google Scholar 

  18. Longman RJ, Thomas MG, Poulsom R (1999) Trefoil peptides and surgical disease. Br J Surg 86:740–748

    Google Scholar 

  19. Machado JC, Carneiro F, Ribeiro P, Blin P, Sobrinho-Simoes M (1996) pS2 protein expression in gastric carcinoma. An immunohistochemical and immunoradiometric study. Eur J Cancer 32A:1585–1590

    Google Scholar 

  20. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P (1982) Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast-cancer cell line. Nucleic Acids Res 10:7895–7903

    Google Scholar 

  21. Müller W, Borchard F (1993) pS2 protein in gastric carcinoma and normal gastric mucosa: association with clinicopathological parameters and patient survival. J Pathol 171:263–269

    Google Scholar 

  22. Nocito A, Bubendorf L, Tinner ME, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Anabitarte M, Hering F, Hardmeier T, Schoenenberger AJ, Flury R, Jager P, Fehr LJ, Schraml P, Moch H, Mihatsch MJ, Gasser T, Sauter G (2001) Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 194:349–357

    Article  CAS  PubMed  Google Scholar 

  23. North JH Jr, Pack MS, Hong C, Rivera DE (1998) Prognostic factors for adenocarcinoma of the gallbladder: an analysis of 162 cases. Am Surg 64:437–440

    Google Scholar 

  24. Parwani AV, Geradts J, Caspers E, Offerhaus GJ, Yeo CJ, Cameron JL, Klimstra DS, Maitra A, Hruban RH, Argani P (2003) Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Mod Pathol 16:299–308

    Google Scholar 

  25. Ribieras S, Lefebvre O, Tomasetto C, Rio MC (2001) Mouse Trefoil factor genes: genomic organization, sequences and methylation analyses. Gene 266:67–75

    Google Scholar 

  26. Roa I, Araya JC, Villaseca M, de Artxabala X, Ferreira A, Roa JC (1995) Gallbladder cancer: immunohistochemical expression of the protein related to estrogen receptor (p29) and of the protein induced by estrogen (pS2). Rev Med Chile 123:1333–1340

    Google Scholar 

  27. Rodrigues S, van Aken E, van Bocxlaer S, Attoub S, Nguyen QD, Bruyneel E, Westley BR, May FEB, Thim L, Mareel M, Gespach C, Enami S (2003) Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling. FASEB J 17:7–16

    Article  CAS  PubMed  Google Scholar 

  28. Rodrigues S, Attoub S, Nguyen QD, Bruyneel E, Rodrigue CM, Westley BR, May FEB, Thim L, Mareel M, Emami S, Gespach C (2003) Selective abrogation of the proinvasive activity of the trefoil peptides pS2 and spasmolytic polypeptide by disruption of the EGF receptor signaling pathways in kidney and colonic cancer cells. Oncogene 22:4488–4497

    Article  CAS  PubMed  Google Scholar 

  29. Sagol O, Tuna B, Coker A, Karademir S, Obuz F, Astarcioglu H, Kupelioglu A, Astracioglu I, Topalak O (2002) Immunohistochemical detection of pS2 protein and heat shock protein-70 in pancreatic adenocarcinomas. Relationship with disease extent and patient survival. Pathol Res Pract 198:77–84

    Google Scholar 

  30. Sasaki M, Tsuneyama K, Nakanuma Y (2003) Aberrant expression of trefoil factor family 1 in biliary epithelium in hepatolithiasis and cholangiocarcinoma. Lab Invest 83:1403–1413

    Google Scholar 

  31. Seitz G, Thelsinger B, Tomasetto G, Rio MC, Chambon P, Blin N, Welter G (1991) Breast cancer—associated protein pS2 expression in tumors of the biliary tract. Am J Gastroenterol 86:1491–1494

    Google Scholar 

  32. Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York

    Google Scholar 

  33. Srivatsa G, Giraud AS, Ulaganathan M, Yeomans ND, Dow C, Nicoll AJ (2002) Biliary epithelial trefoil peptide expression is increased in biliary diseases. Histopathology 40:262–268

    Google Scholar 

  34. Suarez C, Vizoso F, Rodriguez JC, Garcia I, Raigoso P, Allende MT, Garcia-Muniz JL, Garcia-Moran M (2001) Prognostic significance of cytosolic pS2 protein content in gastric cancer. Int J Biol Markers 16:37–44

    Google Scholar 

  35. Taupin D, Podolsky DK (2003) Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 4:721–732

    Google Scholar 

  36. Tazuma S, Kajiyama G (2001) Carcinogenesis of malignant lesions of the gallbladder. The impact of chronic inflammation and gallstones. Langenbeck’s Arch Surg 386:224–229

    Google Scholar 

  37. Tomasetto C, Masson R, Linares JL, Wendling C, Lefevre O, Chenard MP, Rio MC (2000) pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology 118:70–80

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Medical University of Graz, Auenbruggerplatz 29, 8036, Graz, Austria

    Peter Kornprat & Martina Lemmerer

  2. Division of Biomedical Engineering & Computing, Medical University of Graz, Auenbruggerplatz 29, 8036, Graz, Austria

    Peter Rehak

  3. Institute of Pathology, Medical University of Graz, Auenbruggerplatz 25, 8036, Graz, Austria

    Margit Gogg-Kamerer & Cord Langner

Authors
  1. Peter Kornprat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Rehak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martina Lemmerer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Margit Gogg-Kamerer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cord Langner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cord Langner.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kornprat, P., Rehak, P., Lemmerer, M. et al. Analysis of trefoil factor family protein 1 (TFF1, pS2) expression in chronic cholecystitis and gallbladder carcinoma. Virchows Arch 446, 505–510 (2005). https://doi.org/10.1007/s00428-005-1240-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-005-1240-4

Keywords

  • TFF1
  • pS2
  • Gallbladder carcinoma
  • Pathogenesis
  • Prognosis